Symptoms and Otorhinolaryngological Sequalae in Long Covid

Alessandra Loli; João Victor Costa Müller; Eric Schneider de Azevedo; Regina Helena Garcia Martins

doi:10.1055/s-0045-1809026

International Archives of Otorhinolaryngology, Inhaltsverzeichnis

CC BY 4.0 · Int Arch Otorhinolaryngol 2025; 29(02): s00451809026
DOI: 10.1055/s-0045-1809026

Original Research

Symptoms and Otorhinolaryngological Sequalae in Long Covid

Alessandra Loli

¹Department of Ophthalmology, Otorhinolaryngology, and Head and Neck Surgery, Universidade Estadual Paulista Julio de Mesquita Filho, Botucatu Medical School, Unesp, São Paulo, SP, Brazil

,

João Victor Costa Müller

²Department of Surgical Specialties and Anesthesiology, Universidade Estadual paulista Júlio de Mesquita Filho, Botucatu Medical School, Unesp, São Paulo, Brazil

,

Eric Schneider de Azevedo

²Department of Surgical Specialties and Anesthesiology, Universidade Estadual paulista Júlio de Mesquita Filho, Botucatu Medical School, Unesp, São Paulo, Brazil

,

Regina Helena Garcia Martins

¹Department of Ophthalmology, Otorhinolaryngology, and Head and Neck Surgery, Universidade Estadual Paulista Julio de Mesquita Filho, Botucatu Medical School, Unesp, São Paulo, SP, Brazil

› Institutsangaben

Abstract

Introduction

After the pandemic caused by the coronavirus, many patients have presented remaining otorhinolaryngological symptoms, but most of them are unknown to health professionals.

Objectives

To characterize otorhinolaryngological symptoms and sequelae in hospitalized patients for Covid-19.

Methods

We made a recall to patients hospitalized between April 2020 and April 2022 due to Covid-19. Demographic data, initial and remaining symptoms, days of hospitalization, intubation and/or tracheostomy, and vaccination data were collected.

Results

845 patients were hospitalized, 441 died, 404 patients were contacted by telephone, but only 109 responded to the questionnaire about initial and remaining otorhinolaryngological symptoms after 1.5 to 2 years of illness, 59 men and 50 women, with an average age of 58.61 years (20 to 94). Two study groups were composed: G 1 (n- 44; with remaining symptoms) and G 2 (n- 65; without remaining symptoms). 81% of patients in G1 and 67% of patients in G2 had been hospitalized for up to 20 days. Intubation occurred in 17 patients (G1–7; G2–10). Seven patients underwent tracheostomy. The most prevalent initial and remaining otorhinolaryngological symptoms, respectively, were dyspnea (68.8%; 14.6%), cough (65.1%; 11.92%), nasal obstruction (47.7%; 5.58%), smell dysfunction (44%; 11%), taste dysfunction (42%; 4.58%). Vaccination was reported by 54 patients (G1–21; G2–34).

Conclusions

Otorhinolaryngological symptoms were common in patients hospitalized for Covid-19, especially dyspnea, cough, nasal obstruction, smell, and taste dysfunction. Although there was a favorable long-term evolution, 40% of patients maintained permanent symptoms, such as smell and taste dysfunction and dizziness, unrelated to the vaccine doses.

Keywords

long covid - otorhinolaryngological sequelae - otorhinolaryngological symptoms

Bibliographical Record
Alessandra Loli, João Victor Costa Müller, Eric Schneider de Azevedo, Regina Helena Garcia Martins. Symptoms and Otorhinolaryngological Sequalae in Long Covid. Int Arch Otorhinolaryngol 2025; 29: s00451809026.
DOI: 10.1055/s-0045-1809026

Volltext

Referenzen

References
1 Guan W, Ni Z, Hu Y. et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. J Emerg Med 2020; 58: 711-712
2 Mohamadian M, Chiti H, Shoghli A, Biglari S, Parsamanesh N, Esmaeilzadeh A. COVID-19: Virology, biology and novel laboratory diagnosis. J Gene Med 2021; 23 (02) e3303
3 Krajewska J, Krajewski W, Zub K, Zatoński T. COVID-19 in otolaryngologist practice: a review of current knowledge. Eur Arch Otorhinolaryngol 2020; 277 (07) 1885-1897
4 Elibol E. Otolaryngological symptoms in COVID-19. Eur Arch Otorhinolaryngol 2021; 278 (04) 1233-1236
5 Özçelik Korkmaz M, Eğilmez OK, Özçelik MA, Güven M. Otolaryngological manifestations of hospitalised patients with confirmed COVID-19 infection. Eur Arch Otorhinolaryngol 2021; 278 (05) 1675-1685
6 Walker A, Pottinger G, Scott A, Hopkins C. Anosmia and loss of smell in the era of covid-19. BMJ 2020; 370: m2808
7 Whitcroft KL, Hummel T. Olfactory Dysfunction in COVID-19: Diagnosis and Management. JAMA 2020; 323 (24) 2512-2514
8 Lechien JR, Chiesa-Estomba CM, De Siati DR. et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol 2020; 277 (08) 2251-2261
9 Freni F, Meduri A, Gazia F. et al. Symptomatology in head and neck district in coronavirus disease (COVID-19): A possible neuroinvasive action of SARS-CoV-2. Am J Otolaryngol 2020; 41 (05) 102612
10 McIntyre KM, Favre NM, Kuo CC, Carr MM. Systematic Review of Sensorineural Hearing Loss Associated With COVID-19 Infection. Cureus 2021; 13 (11) e19757
11 Al-Ani RM, Rashid RA. Prevalence of dysphonia due to COVID-19 at Salahaddin General Hospital, Tikrit City, Iraq. Am J Otolaryngol 2021; 42 (05) 103157
12 Martín Carreras-Presas C, Amaro Sánchez J, López-Sánchez AF, Jané-Salas E, Somacarrera Pérez ML. Oral vesiculobullous lesions associated with SARS-CoV-2 infection. Oral Dis 2021; 27 (Suppl 3, Suppl 3) 710-712
13 Regan J, Walshe M, Lavan S. et al. Dysphagia, Dysphonia, and Dysarthria Outcomes Among Adults Hospitalized With COVID-19 Across Ireland. Laryngoscope 2022; 132 (06) 1251-1259
14 Colizza A, Ralli M, Turchetta R, Minni A, Greco A, de Vincentiis M. Otolaryngology adverse events following COVID-19 vaccines. Eur Rev Med Pharmacol Sci 2022; 26 (11) 4113-4116
15 Qiu J, Yang X, Liu L. et al. Prevalence and prognosis of otorhinolaryngological symptoms in patients with COVID-19: a systematic review and meta-analysis. Eur Arch Otorhinolaryngol 2022; 279 (01) 49-60
16 Salepci E, Turk B, Ozcan SN. et al. Symptomatology of COVID-19 from the otorhinolaryngology perspective: a survey of 223 SARS-CoV-2 RNA-positive patients. Eur Arch Otorhinolaryngol 2021; 278 (02) 525-535
17 Xiong Q, Xu M, Li J. et al. Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study. Clin Microbiol Infect 2021; 27 (01) 89-95
18 Boscolo-Rizzo P, Fabbris C, Polesel J. et al. Two-Year Prevalence and Recovery Rate of Altered Sense of Smell or Taste in Patients With Mildly Symptomatic COVID-19. JAMA Otolaryngol Head Neck Surg 2022; 148 (09) 889-891
19 Tan BKJ, Han R, Zhao JJ. et al. Prognosis and persistence of smell and taste dysfunction in patients with covid-19: meta-analysis with parametric cure modelling of recovery curves. BMJ 2022; 378: e069503
20 Krishnakumar HN, Momtaz DA, Sherwani A. et al. Pathogenesis and progression of anosmia and dysgeusia during the COVID-19 pandemic. Eur Arch Otorhinolaryngol 2023; 280 (02) 505-509
21 Liao B, Deng YK, Zeng M, Liu Z. Long-term Consequences of COVID-19: Chemosensory Disorders. Curr Allergy Asthma Rep 2023; 23 (02) 111-119
22 Aydin S, Koca CF, Celik T, Kelles M, Yasar S, Oguzturk S. The effect of the severity of COVID-19 on the sequelae of the audiovestibular system. Ear Nose Throat J 2023; 102 (05) 336-343
23 Misra S, Kolappa K, Prasad M. et al. Frequency of Neurologic Manifestations in COVID-19: A Systematic Review and Meta-analysis. Neurology 2021; 97 (23) e2269-e2281
24 Tan M, Cengiz DU, Demir İ. et al. Effects of Covid-19 on the audio-vestibular system. Am J Otolaryngol 2022; 43 (01) 103173
25 De Luca P, Di Stadio A, Colacurcio V. et al. Long COVID, audiovestibular symptoms and persistent chemosensory dysfunction: a systematic review of the current evidence. Acta Otorhinolaryngol Ital 2022; 42 (Suppl. 01) S87-S93
26 O'Mahoney LL, Routen A, Gillies C. et al. Corrigendum to “The prevalence and long-term health effects of long Covid among hospitalised and non-hospitalised populations: a systematic review and meta-analysis”. EClinicalMedicine 2023; 59: 101959
27 Reiter ER, Coelho DH, French E, Costanzo RM. N3C Consortium. COVID-19-Associated Chemosensory Loss Continues to Decline. Otolaryngol Head Neck Surg 2023; 169 (05) 1386-1389
28 Arjun MC, Singh AK, Pal D. et al. Characteristics and predictors of Long COVID among diagnosed cases of COVID-19. PLoS One 2022; 17 (12) e0278825
29 Bianco MR, Ralli M, Minni A, Greco A, de Vincentiis M, Allegra E. Evaluation of olfactory dysfunction persistence after COVID-19: a prospective study. Eur Rev Med Pharmacol Sci 2022; 26 (03) 1042-1048
30 Lechien JR, Chiesa-Estomba CM, Cabaraux P. et al. Features of Mild-to-Moderate COVID-19 Patients With Dysphonia. J Voice 2022; 36 (02) 249-255
31 Cantarella G, Aldè M, Consonni D. et al. Prevalence of dysphonia in non hospitalized patients with COVID-19 in Lombardy, the Italian epicenter of the pandemic. J Voice 2023; 37 (04) 605-609